Member Info for DeAar

Matt,

The upfront payments are going to be in the same ballpark as the Genmab deal. Lindy said this (you've mentioned that today too). I dont think exclusivity would increase the initial payment by that much, but the overall deal and milestone payments would be bigger.

Well the third and fourth drawdown become available on the 4th February. £300000 for the third and £1400000 for the fourth. Yes, another £1.7 million in February. They took the second in November and unless there's a miracle, they will take the third and fourth too.

It's Sath, not Seth.

American football is brutal. Average playing career is only around three years due to the high injury rates. Rugby league is soft as in comparison.

You spend your days defending Sareum on this BB Carter. You're worried. If you weren't, you'd chill and hardly ever post.

Drac,

You're not immortal?

Rigga,

You may want to be out of this over the weekend.

So it appears Scancell is a leaky ship nowadays....

Sign of the times. Traders happy to settle for a quick 5% or 10% scalp. It is what it is.

I queried the patent expiry via the website a couple of days after the RNS. I've also not had a response.

When have Sareum ever delivered on any promised deadline? Everything has always been delayed. And now Ahfam, you think results will be early. Yes, the trial is out of their hands but H1 24 means any time till the end of June. Then there is the matter of getting P1b underway "as soon as possible". We'll how long is a piece of string, especially in the delay filled world of Sareum? And this is where the risk really lies. They are are only funded to the end of P1b, and with the worst possible finance at that. What would a delay do to the finances? What if they finish P1b with no money, or run out during the trial? Any company looking to procure the molecules will have a major advantage and Sareum will get the bare minimum as they will not be in a strong bargaining position. There will be a low ball buy out or licencing with unfavourable terms for Sareum. Big Pharma is ruthless and Sareum may have painted themselves into a corner.

Ooh, it looks ike Ahfam has found himself a yapping lapdog. Good boy Carter. Sit. Stay.

You need to shell out a bit for GPT-4 for accurate up to date information.

Morning Ruck,

ChatGPT is no longer limited to data before September 2021.

https://twitter.com/OpenAI/status/1707077710047216095?t=ZFCqepVdpKsa_n0BoHCJPQ&s=19

Ahfam,

And then you go and call somebody "it". That is also seriously derogatory but I suppose you have no compass.

Could use the ink for a big cheque?

There you go again making things up Ahfam. There will be no P1a data in December. What is it you don't understand about the RNS's stating H1 24? The readout will be sometime between January and the end June 2024.

This BB is getting pretty negative again. Looks like a good time to buy to me. The last time negativity like this was in full flourish was just before the SCOPE RNS in September.

Ahfam,

Sareum have released numerous RNS's that have stated P1a results will be available in H1 24. I'll believe them, not you.

I wish someone would pay me to post here. So you're wrong there too.

For years you've been saying Sareum is going to explode and look where the SP is now. So far you've been wrong on this too.

Never say never with the market as it is at the moment.

"Antibodies have been blown out the water". 🤣

Those writing the big cheques don't think so.